Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/2003
12/04/2003US20030224019 Administering a therapeutically effective amount of Botulinum toxin type B to a patient suffering from nerve entrapment syndrome ( carpal tunnel syndrome, piriformis syndrome, cubital tunnel syndrome, and radial tunnel syndrome)
12/04/2003US20030223992 G-protein coupled receptor ligands and methods
12/04/2003US20030223991 Modulating activity of the immune system using agonists or antagonists of a CD200 receptor. Also provided are methods of treatment and diagnosis of immune disorders.
12/04/2003US20030223981 Peptide inhibitors of protein kinase C gamma for pain management
12/04/2003US20030223972 Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells
12/04/2003US20030223969 Method of modulating inflammatory response
12/04/2003CA2784937A1 Ccr9 inhibitors and methods of use thereof
12/04/2003CA2490542A1 Fas peptide mimetics and uses thereof
12/04/2003CA2487732A1 Cardiac glycosides to treat cystic fibrosis and other il-8 dependent disorders
12/04/2003CA2487557A1 Modulators and inhibitors of fibroblast growth factor receptor 5 polypeptides and gene expression thereof
12/04/2003CA2487441A1 Novel uses of parapoxvirus preparations
12/04/2003CA2487273A1 Agents and methods for the treatment of disorders associated with oxidative stress
12/04/2003CA2487246A1 Novel uses of cephaibols
12/04/2003CA2487153A1 New formulation for the parenteral application of crobenetine
12/04/2003CA2487143A1 Regulation of novel human asparagine-hydroxylases
12/04/2003CA2486966A1 Substituted quinazolinone compounds
12/04/2003CA2486962A1 Compounds
12/04/2003CA2486853A1 Bis-aromatic alkanols
12/04/2003CA2486821A1 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
12/04/2003CA2486753A1 8-fluorimidazo'1,2-a!pyridine derivatives as ligands for gaba receptors
12/04/2003CA2486750A1 Imidazo-pyridine derivatives as ligands for gaba receptors
12/04/2003CA2486716A1 Compositions and their uses for alleviating pain
12/04/2003CA2486709A1 Adduct of topiramate and tramadol hydrochloride and uses thereof
12/04/2003CA2486651A1 Sulfone liver x-receptor modulators
12/04/2003CA2486644A1 Anilino liver x-receptor modulators
12/04/2003CA2486564A1 Acetamides and benzamides that are useful in treating sexual dysfunction
12/04/2003CA2486376A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
12/04/2003CA2485184A1 Methods for the identification of ikkalpha function and other genes useful for treatment of inflammatory diseases
12/04/2003CA2485166A1 Substituted pyrimidinone and pyridinone compounds
12/04/2003CA2484822A1 Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions
12/04/2003CA2484288A1 Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
12/04/2003CA2484274A1 Compositions and methods of use for a fibroblast growth factor
12/04/2003CA2480742A1 Tropane compounds
12/03/2003EP1367123A1 Neurotonin and use thereof
12/03/2003EP1367056A1 Drugs that enhance synaptic responses mediated by AMPA receptors
12/03/2003EP1367055A1 Isoquinolinyl carboxamides and their use as anticonvulsants
12/03/2003EP1366771A2 Use of the neurotoxic compnent of botulinum toxins as a medicament
12/03/2003EP1366770A2 Use of botulinum toxin for treating muscle-associated pain
12/03/2003EP1366765A1 Use of matrix metalloproteinase inhibitors for treating neurological disorders and promoting wound healing
12/03/2003EP1366180A2 Use of mutations of mec-1 and its related genes in the identification of compounds for treatment of disease
12/03/2003EP1366165A2 G-protein coupled receptors
12/03/2003EP1366162A2 Putative proteins and nucleic acids encoding same
12/03/2003EP1366161A2 Interleukin-8 homologous polypeptides and therapeutic uses thereof
12/03/2003EP1366152A2 G-protein coupled receptors
12/03/2003EP1366150A2 Use of protein histidine phosphatase
12/03/2003EP1366146A2 Isolated nucleic acid molecules encoding a novel human signal transducing kinase-mapkap-2; encoded proteins, cells transformed therewith and uses thereof
12/03/2003EP1366079A2 Nuclear hormone receptor ligand binding domain
12/03/2003EP1366078A2 Ige receptor antagonists
12/03/2003EP1366075A2 New interferon beta-like molecules
12/03/2003EP1366044A1 8-[4-[3-(5-fluoro-1h-indol-3-yl)propyl]-1-piperazinyl]-2-methyl-2h-1, 4-benzoxazin-3(4h)-one methanesulfonate with high affinity for the dopamine d2 receptor and the serotonin reuptake site
12/03/2003EP1366042A1 Process to produce paroxetine
12/03/2003EP1366039A1 Piperazinylcarbonylquinolines and -isoquinolines
12/03/2003EP1366030A2 Melanin concentrating hormone receptor ligands
12/03/2003EP1366029A1 Substituted 2-oxo-3-phenyl-5-carbonylaminomethyl-1,3-oxazolins and the utilization thereof as anticoagulant and antithrombotic agents
12/03/2003EP1366025A1 Agonists of beta-adrenoceptors
12/03/2003EP1366024A2 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
12/03/2003EP1366020A1 Urea derivatives having vanilloid receptor (vr1) antagonist activity
12/03/2003EP1366012A2 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders
12/03/2003EP1366007A2 Compounds with high monoamine transporter affinity
12/03/2003EP1365812A2 Pharmaceutical composition having reduced tendency for drug crystallization
12/03/2003EP1365809A2 Methods for reducing chronic stress in mammals
12/03/2003EP1365800A2 Methods for using tetanus toxin for benificial purposes in animals (mammals)
12/03/2003EP1365798A2 Use of serp-1 in combination with an immunosuppressant for influencing inflammatory and immune reactions
12/03/2003EP1365788A2 Thrombomodulin analogs for use in recovery of signal cord injury
12/03/2003EP1365787A2 New uses for amino acid anticonvulsants for treatment of pain
12/03/2003EP1365785A2 Use of ciliary neurotrophic factor
12/03/2003EP1365761A1 Therapeutic combination of amlodipine and benazepril
12/03/2003EP1365758A2 Method for modulation, stimulation, and inhibition of glutamate reuptake
12/03/2003EP1365752A2 Methods for the treatment of a traumatic central nervous system injury with e.g. allopregnanolone
12/03/2003EP1365748A2 Particulate composition of eletriptan showing a sigmoidal pattern of controlled release
12/03/2003EP1365737A2 Stable salts of o-acetylsalicyclic with basic amino acids
12/03/2003EP1283838B1 Piperazine and piperidine compounds
12/03/2003EP1257555B1 Pyrimidine compounds and their use as modulators of chemokine receptor activity
12/03/2003EP1178953B1 Aromatic amides
12/03/2003EP1150963B1 Substituted 4-amino-2-aryltetrahydroquinazolines, their preparation, their use and pharmaceutical compositions comprising them
12/03/2003EP1135383B1 Mixed paroxetine propan-2-ol solvates
12/03/2003EP1082304B1 NEW CRYSTALLINE POLYMORPHIC FORM OF 1-METHYL-5-p-TOLUOYLPYRROLE-2-ACETAMIDOACETIC ACID GUAIACYL ESTER (MED 15)
12/03/2003EP1015437B1 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals
12/03/2003CN1460108A Water soluble rapamycin esters
12/03/2003CN1460025A Immunomodulatory human MHC class Ôàí antigen-binding polypeptides
12/03/2003CN1460019A Improved injectable dispersions of propofol
12/03/2003CN1459448A Preparation method of red sageroot total phenolic acid and its use
12/03/2003CN1459308A Series medicines for treating headache
12/03/2003CN1459287A Cytophosphocholine sodium quantitative drop
12/03/2003CN1459286A Tetrodotoxin respiratory tract administration prepn. used for giving-up drug and easing pain
12/03/2003CN1129606C Heptapeptide oxytocin analogues
12/03/2003CN1129605C Modified aminoacids, pharmaceuticals containing these compounds and mehtod for their prodn
12/03/2003CN1129602C 11-(substituted phenyl) estra-4,9-diene derivatives
12/03/2003CN1129599C Substituted benzothiazine/oxazine-2-amide derivatives, their prepn and application
12/03/2003CN1129592C Method for preparation of citalopram
12/03/2003CN1129582C 3-substituted-4-arylquinolin-2-one derivatives as potassium channel modulators
12/03/2003CN1129579C 1-phenylalkyl-1,2,3,6-tetrahydropyridines for treating alzheimer's disease
12/03/2003CN1129577C 维生素d3衍生物 Derivatives of vitamin d3
12/03/2003CN1129576C Phenyl heterocyclic compound used as epoxy enzyme-2 inhibitor
12/03/2003CN1129427C TTS contg. antioxidant
12/03/2003CA2431795A1 Topical and oral administration of a composition containing pelargonium graveolens for diagnosis and treatment of various neuralgias and other conditions
12/02/2003US6657070 Production of chirally pure α-amino acids and N-sulfonyl α-amino acids
12/02/2003US6657064 For use as analgesics
12/02/2003US6656972 Tetrahydrocannabinol; side effect reduction
12/02/2003US6656971 Non-peptidic small organic compounds having an affinity for cyclophilin (CyP)-type immunophilins; inhibiting their peptidyl-prolyl isomerase activity; treating variety of medical conditions
1 ... 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 ... 1833